These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 8866657)

  • 21. Preliminary clinical study of the distribution of HPMA copolymers bearing doxorubicin and galactosamine.
    Julyan PJ; Seymour LW; Ferry DR; Daryani S; Boivin CM; Doran J; David M; Anderson D; Christodoulou C; Young AM; Hesslewood S; Kerr DJ
    J Control Release; 1999 Feb; 57(3):281-90. PubMed ID: 9895415
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fate of N-(2-hydroxypropyl)methacrylamide copolymers with pendent galactosamine residues after intravenous administration to rats.
    Duncan R; Seymour LC; Scarlett L; Lloyd JB; Rejmanová P; Kopecek J
    Biochim Biophys Acta; 1986 Jan; 880(1):62-71. PubMed ID: 3942780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Passive and active hepatoma tumor targeting of new N-(2-hydroxypropyl)methacrylamide copolymer conjugates: synthesis, characterization, and evaluation in vitro and in vivo.
    Yuan J; Yuan B; Guo H; Zeng X; Wang X; Liao S; Li J; Jia Z; Song F; Wang F
    J Biomater Sci Polym Ed; 2013; 24(12):1472-83. PubMed ID: 23829459
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PDEPT: polymer-directed enzyme prodrug therapy. I. HPMA copolymer-cathepsin B and PK1 as a model combination.
    Satchi R; Connors TA; Duncan R
    Br J Cancer; 2001 Sep; 85(7):1070-6. PubMed ID: 11592781
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination chemotherapy and photodynamic therapy of targetable N-(2-hydroxypropyl)methacrylamide copolymer-doxorubicin/mesochlorin e(6)-OV-TL 16 antibody immunoconjugates.
    Shiah JG; Sun Y; Kopecková P; Peterson CM; Straight RC; Kopecek J
    J Control Release; 2001 Jul; 74(1-3):249-53. PubMed ID: 11489502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HPMA copolymer-anticancer drug-OV-TL16 antibody conjugates. 1. influence of the method of synthesis on the binding affinity to OVCAR-3 ovarian carcinoma cells in vitro.
    Omelyanenko V; Kopecková P; Gentry C; Shiah JG; Kopecek J
    J Drug Target; 1996; 3(5):357-73. PubMed ID: 8866655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targetable HPMA copolymer-adriamycin conjugates. Recognition, internalization, and subcellular fate.
    Omelyanenko V; Kopecková P; Gentry C; Kopecek J
    J Control Release; 1998 Apr; 53(1-3):25-37. PubMed ID: 9741911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced cardiotoxicity of doxorubicin given in the form of N-(2-hydroxypropyl)methacrylamide conjugates: and experimental study in the rat.
    Yeung TK; Hopewell JW; Simmonds RH; Seymour LW; Duncan R; Bellini O; Grandi M; Spreafico F; Strohalm J; Ulbrich K
    Cancer Chemother Pharmacol; 1991; 29(2):105-11. PubMed ID: 1760851
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel.
    Šírová M; Strohalm J; Chytil P; Lidický O; Tomala J; Říhová B; Etrych T
    J Control Release; 2017 Jan; 246():1-11. PubMed ID: 27940304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of galactose, lactose, and galactose valency in the biorecognition of N-(2-hydroxypropyl)methacrylamide copolymers by human colon adenocarcinoma cells.
    David A; Kopecková P; Kopecek J; Rubinstein A
    Pharm Res; 2002 Aug; 19(8):1114-22. PubMed ID: 12240936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Overcoming multidrug resistance via simultaneous delivery of cytostatic drug and P-glycoprotein inhibitor to cancer cells by HPMA copolymer conjugate.
    Sivak L; Subr V; Tomala J; Rihova B; Strohalm J; Etrych T; Kovar M
    Biomaterials; 2017 Jan; 115():65-80. PubMed ID: 27886555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Polymeric conjugates of mono- and bi-cyclic alphaVbeta3 binding peptides for tumor targeting.
    Mitra A; Coleman T; Borgman M; Nan A; Ghandehari H; Line BR
    J Control Release; 2006 Aug; 114(2):175-83. PubMed ID: 16889865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New HPMA copolymers containing doxorubicin bound via pH-sensitive linkage: synthesis and preliminary in vitro and in vivo biological properties.
    Etrych T; Jelínková M; Ríhová B; Ulbrich K
    J Control Release; 2001 May; 73(1):89-102. PubMed ID: 11337062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessing the therapeutic efficacy of VEGFR-1-targeted polymer drug conjugates in mouse tumor models.
    Shamay Y; Golan M; Tyomkin D; David A
    J Control Release; 2016 May; 229():192-199. PubMed ID: 27001892
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conjugates of doxorubicin with graft HPMA copolymers for passive tumor targeting.
    Etrych T; Chytil P; Mrkvan T; Sírová M; Ríhová B; Ulbrich K
    J Control Release; 2008 Dec; 132(3):184-92. PubMed ID: 18534705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of prostate carcinoma with (galectin-3)-targeted HPMA copolymer-(G3-C12)-5-Fluorouracil conjugates.
    Yang Y; Zhou Z; He S; Fan T; Jin Y; Zhu X; Chen C; Zhang ZR; Huang Y
    Biomaterials; 2012 Mar; 33(7):2260-71. PubMed ID: 22189143
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Peptide-directed HPMA copolymer-doxorubicin conjugates as targeted therapeutics for colorectal cancer.
    Kopansky E; Shamay Y; David A
    J Drug Target; 2011 Dec; 19(10):933-43. PubMed ID: 22074249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cytostatic and immunomobilizing activities of polymer-bound drugs: experimental and first clinical data.
    Ríhová B; Strohalm J; Prausová J; Kubácková K; Jelínková M; Rozprimová L; Sírová M; Plocová D; Etrych T; Subr V; Mrkvan T; Kovár M; Ulbrich K
    J Control Release; 2003 Aug; 91(1-2):1-16. PubMed ID: 12932633
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preclinical evaluation of the cardiotoxicity of PK2: a novel HPMA copolymer-doxorubicin-galactosamine conjugate antitumour agent.
    Hopewel JW; Duncan R; Wilding D; Chakrabarti K
    Hum Exp Toxicol; 2001 Sep; 20(9):461-70. PubMed ID: 11776408
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cooperativity between free and N-(2-hydroxypropyl) methacrylamide copolymer bound adriamycin and meso-chlorin e6 monoethylene diamine induced photodynamic therapy in human epithelial ovarian carcinoma in vitro.
    Lu JM; Peterson CM; Guo-Shiah J; Gu ZW; Peterson CA; Straight RC; Kopecek J
    Int J Oncol; 1999 Jul; 15(1):5-16. PubMed ID: 10375588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.